Tsujinaka Hospital Kashiwanoha
Kashiwa, Japan
General hospital in Kashiwa
〒277-0871 Chiba, Kashiwa, Wakashiba, 178-2 １４８街区６ 柏の葉キャンパス
About Tsujinaka Hospital Kashiwanoha
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Arena Pharmaceuticals
2
Eli Lilly and Company
2
Pfizer
2
Amgen
1
Celgene
1
Janssen Pharmaceutical K.K.
1
Janssen-Cilag Ltd.
1
Takeda
1
Clinical Trials at Tsujinaka Hospital Kashiwanoha
During the past decade, Tsujinaka Hospital Kashiwanoha conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
2019-06-03
2025-02-28
Active, not recruiting
195
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2019-07-23
2023-12-06
Active, not recruiting
1,100
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2020-06-22
2027-04-22
Recruiting
778
Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)
2020-12-25
2022-08-03
Completed
42
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tsujinaka Hospital Kashiwanoha" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Arena Pharmaceuticals" with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tsujinaka Hospital Kashiwanoha"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Tsujinaka Hospital Kashiwanoha
According to Clinical.Site data, the most researched conditions in "Tsujinaka Hospital Kashiwanoha" are
"Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (1 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "Tsujinaka Hospital Kashiwanoha" in a lesser frequency.
Clinical Trials Intervention Types at Tsujinaka Hospital Kashiwanoha
Most popular intervention types in "Tsujinaka Hospital Kashiwanoha" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Etrasimod" (4 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Tsujinaka Hospital Kashiwanoha
The vast majority of trials in "Tsujinaka Hospital Kashiwanoha" are
15 trials for "All" genders.
Clinical Trials Status at Tsujinaka Hospital Kashiwanoha
Currently, there are NaN active trials in "Tsujinaka Hospital Kashiwanoha".
undefined are not yet recruiting,
8 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Tsujinaka Hospital Kashiwanoha,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tsujinaka Hospital Kashiwanoha, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".